Ignite Creation Date:
2024-05-06 @ 1:55 PM
Last Modification Date:
2024-10-26 @ 1:22 PM
Study NCT ID:
NCT04168931
Status:
TERMINATED
Last Update Posted:
2023-01-17
First Post:
2019-11-05
Brief Title:
Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC
Sponsor:
AC Camargo Cancer Center
Organization:
AC Camargo Cancer Center
Organization Data
Organization:
AC Camargo Cancer Center
Class:
OTHER
Study ID:
279319
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AC Camargo Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Rachel Riechelmann
Responsible Party Title:
Head of Clinical Oncology Department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
AC Camargo Cancer Center
Old Name:
None
Old Organization:
None